SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Harte Hanks, Inc. (HRTH) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 27/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — HRTH
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.38
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.11
Book Value / Share$0.00
Revenue / Share$21.58
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2013 |
$0.21 |
$559.61M |
$13.37M |
2.4% |
| 2014 |
$0.38 |
$553.68M |
$23.99M |
4.3% |
| 2015 |
$-2.77 |
$495.3M |
$-170.93M |
-34.5% |
| 2016 |
$-2.13 |
$404.41M |
$-130.94M |
-32.4% |
| 2017 |
$-6.76 |
$383.91M |
$-41.86M |
-10.9% |
| 2018 |
$2.80 |
$284.63M |
$17.55M |
6.2% |
| 2019 |
$-4.18 |
$217.58M |
$-26.26M |
-12.1% |
| 2020 |
$-0.27 |
$176.9M |
$-1.69M |
-1% |
| 2024 |
$-4.15 |
$185.24M |
$-30.3M |
-16.4% |
| 2025 |
$-0.11 |
$159.57M |
$-811K |
-0.5% |
